AP NEWS

Gamida Cell to Present at BMO Capital Markets Prescriptions for Success Healthcare Conference

November 28, 2018

BOSTON--(BUSINESS WIRE)--Nov 28, 2018--Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that Julian Adams, Ph.D., the company’s chief executive officer, will participate in a fireside chat at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference on Wednesday, December 12 th at 1:20 p.m. ET in New York, NY.

A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, at www.gamida-cell.com and will be available for at least 30 days following the event.

About Gamida Cell Gamida Cell is a clinical stage biopharmaceutical company leveraging its proprietary technology to develop cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The company is leveraging its nicotinamide-, or NAM-, based cell expansion technology to develop a pipeline of products designed to address the limitations of cell therapies.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181128005056/en/

CONTACT: Investor and Media Inquiries:

Jaren Irene Madden

jaren@gamida-cell.com

1-617-286-6264

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS ONCOLOGY PHARMACEUTICAL

SOURCE: Gamida Cell Ltd.

Copyright Business Wire 2018.

PUB: 11/28/2018 08:01 AM/DISC: 11/28/2018 08:01 AM

http://www.businesswire.com/news/home/20181128005056/en

AP RADIO
Update hourly